Trials / Conditions / Helicobacter Pylori Infection

Helicobacter Pylori Infection

391 registered clinical trials studyying Helicobacter Pylori Infection — 49 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication NCT07537634	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Phase 4
Not Yet Recruiting	Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound NCT07458490	Assiut University	—
Not Yet Recruiting	Fecal Molecular Susceptibility-guided Hp Rescue Therapy NCT07405697	Shanghai Zhongshan Hospital	Phase 4
Not Yet Recruiting	Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Erad NCT07439445	Peking University First Hospital	N/A
Not Yet Recruiting	Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms NCT07272681	Amany Usama Ahmed Arafa	—
Recruiting	P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication NCT07285096	Yueyue Li	—
Not Yet Recruiting	Comparison of Two Treatment Regimens of Helicobacter Pylori Infection NCT07021729	Rehman Medical Institute - RMI	Phase 4
Recruiting	Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment NCT07139366	Yongquan Shi	Phase 4
Recruiting	Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy NCT07358130	Kaohsiung Medical University	N/A
Recruiting	Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy f NCT07165444	Tanta University	N/A
Not Yet Recruiting	Tailored Vs. Empirical Helicobacter Pylori Infection Treatment NCT06200779	Manuel Coelho da Rocha	Phase 4
Not Yet Recruiting	Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis NCT07159412	Nanjing First Hospital, Nanjing Medical University	N/A
Recruiting	H. Pylori Eradication With Argon Plasma During Endoscopy NCT06529159	Christopher C. Thompson, MD, MSc	N/A
Not Yet Recruiting	The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection NCT06964334	Assiut University	Phase 3
Recruiting	A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring NCT06660342	Phathom Pharmaceuticals, Inc.	—
Not Yet Recruiting	Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication NCT06901375	Nanjing First Hospital, Nanjing Medical University	EARLY_Phase 1
Recruiting	Effect of PPIs on Stool DNA Test for H. Pylori NCT07516262	Shanghai Jiao Tong University School of Medicine	—
Recruiting	VA Dual Sequential Therapy NCT06929962	The First Affiliated Hospital with Nanjing Medical University	Phase 4
Recruiting	Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication NCT06959368	Asian Institute of Gastroenterology, India	Phase 4
Not Yet Recruiting	The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication NCT06777732	Nanjing First Hospital, Nanjing Medical University	EARLY_Phase 1
Recruiting	Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin NCT07242456	First People's Hospital of Hangzhou	Phase 2 / Phase 3
Completed	Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children NCT07086937	Muhammad Aamir Latif	N/A
Completed	Assessing Hp Diagnosis and Treatment Quality of direct-to Consumer Telemedicine in Mainland China NCT06749873	Shandong University	—
Unknown	Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori NCT06299605	Shandong University	N/A
Recruiting	Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic NCT07260006	Can Tho University of Medicine and Pharmacy	N/A
Not Yet Recruiting	Knowledge, and Practice of Helicobacter Pylori Infection NCT06628089	Sohag University	—
Recruiting	Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Pati NCT06546111	Sadat City University	Phase 1 / Phase 2
Completed	Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori Firs NCT06514274	Xijing Hospital of Digestive Diseases	Phase 4
Not Yet Recruiting	The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylo NCT06591494	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2 / Phase 3
Not Yet Recruiting	H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid Arthritis NCT06586567	Assiut University	—
Completed	Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin NCT06551623	TenNor Therapeutics Inc.	Phase 1
Recruiting	High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection NCT06561698	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Optimization of Minocycline for Helicobacter Pylori Rescue Treatment NCT06561711	Shanghai Jiao Tong University School of Medicine	Phase 4
Enrolling By Invitation	Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with NCT06509139	National Cheng-Kung University Hospital	Phase 4
Completed	Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Thera NCT06499649	IBSA Farmaceutici Italia Srl	N/A
Completed	7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication NCT06576882	Alexandria University	Phase 3
Completed	Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter NCT06412588	Nanjing First Hospital, Nanjing Medical University	N/A
Recruiting	Personalised Health Recommendations to the General Population Through an Integrated AI Guided NCT06421324	Fundación para la Investigación del Hospital Clínico de Valencia	N/A
Completed	A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 2 NCT06391177	Phathom Pharmaceuticals, Inc.	Phase 1
Recruiting	White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection NCT06397066	Jilin University	—
Completed	Related Factors of Hp Infection in Physical Examination and Community Population in Hunan Province NCT06399562	The Third Xiangya Hospital of Central South University	—
Unknown	Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole NCT06318104	Hospital General de México Dr. Eduardo Liceaga	Phase 4
Unknown	Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy NCT06351891	Qilu Hospital of Shandong University	Phase 4
Completed	Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobact NCT06340334	Nanjing First Hospital, Nanjing Medical University	N/A
Active Not Recruiting	Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication NCT06396780	Wei XIA, PhD	—
Recruiting	Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment NCT06422052	Shanghai Jiao Tong University School of Medicine	—
Unknown	Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding NCT06273384	Mahidol University	—
Recruiting	Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma NCT06228963	Fudan University	Phase 2
Completed	Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication NCT06340724	Nanjing First Hospital, Nanjing Medical University	Phase 3
Completed	Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobact NCT06250634	The Third Xiangya Hospital of Central South University	N/A
Completed	Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylo NCT06751121	Daewoong Pharmaceutical Co. LTD.	Phase 3
Unknown	Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infe NCT06216639	National Institute of Public Health, Slovenia	—
Completed	Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity NCT07122284	Zhongshan Hospital (Xiamen), Fudan University	—
Completed	Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced G NCT07312721	Azfar Farogh	Phase 4
Not Yet Recruiting	Levofloxacin Concomitant Versus Levofloxacin Sequential NCT06065267	Damascus Hospital	Phase 4
Unknown	Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Ther NCT06603688	Xijing Hospital of Digestive Diseases	Phase 4
Completed	Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Com NCT06156085	Fu Jen Catholic University Hospital	Phase 4
Completed	Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) NCT05647278	Zhang Xiaofeng,MD	Phase 4
Completed	Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori NCT06414707	Ain Shams University	Phase 3
Unknown	Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302 NCT05997433	Shandong University	N/A
Unknown	Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication NCT06037122	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Active Not Recruiting	Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori NCT05957432	Ain Shams University	Phase 2
Suspended	Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment NCT04723472	Shanghai East Hospital	N/A
Recruiting	Doxycycline for Helicobacter Pylori Rescue Treatment NCT05874570	Shanghai Jiao Tong University School of Medicine	Phase 4
Unknown	The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication NCT05658055	Nanjing First Hospital, Nanjing Medical University	Phase 4
Unknown	Role of Vitamin D Supplementation as an Adjuvant Therapy inTreatment of Helicobacter Pylori in Children NCT05879237	Minia University	N/A
Unknown	Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301） NCT05870683	Yanqing Li	N/A
Completed	Rescue Therapy for Helicobacter Pylori Infection NCT05874544	Shanghai Jiao Tong University School of Medicine	Phase 4
Active Not Recruiting	Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy NCT05749081	The First Affiliated Hospital of Nanchang University	Phase 4
Unknown	Prevalence and Risk Factors of Helicobacter Pylori Infection in Children and Young Adults NCT05830357	Sohag University	—
Recruiting	The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients NCT04728516	Qilu Hospital of Shandong University	Phase 4
Unknown	Measurement and Analysis of Gas Composition in Digestive Tract NCT05810805	Xiuli Zuo	—
Completed	The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change NCT07408271	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Unknown	Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencie NCT05802888	Shandong University	Phase 4
Unknown	Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infect NCT05718609	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Unknown	Clinical Utility of Upper Endoscopy in Diagnosis of Helicobacter Pylori Infection NCT05787262	Sohag University	N/A
Unknown	The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu NCT05654857	Nanjing First Hospital, Nanjing Medical University	—
Unknown	Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients NCT05933031	HK inno.N Corporation	Phase 2
Unknown	Effect of Probiotics on Gut Microbiota During the Helicobacter Pylori Eradication NCT05662514	Qilu Hospital of Shandong University	N/A
Unknown	14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infectio NCT05438550	Shandong University	Phase 4
Unknown	Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A NCT06088316	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Phase 4
Unknown	The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial NCT05586113	Shandong University	Phase 4
Unknown	Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylo NCT05726734	Shanghai East Hospital	Phase 4
Unknown	New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non NCT05495854	Poitiers University Hospital	N/A
Completed	Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori NCT05649540	Nanjing First Hospital, Nanjing Medical University	Phase 4
Unknown	Stool Antigen In Diagnosis Of Helicobacter Pylori NCT05802732	Assiut University	—
Recruiting	PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study NCT05681689	ARJ Medical, Inc.	Phase 3
Completed	Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intesti NCT05742568	Xijing Hospital of Digestive Diseases	Phase 4
Unknown	The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection NCT05620602	Shandong University	—
Unknown	The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection NCT05620589	Shandong University	—
Unknown	Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine NCT05586464	Liaocheng People's Hospital	Phase 1
Completed	Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of NCT05577468	Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.	Phase 3
Completed	Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication NCT05664685	Pontificia Universidad Catolica de Chile	Phase 4
Unknown	Fucoidan Assisted Eradication of Helicobacter Pylori NCT05461508	Nanjing First Hospital, Nanjing Medical University	Phase 1 / Phase 2
Unknown	One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL NCT05728424	Aga Khan University	Phase 3
Unknown	Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection NCT05549115	Liaocheng People's Hospital	N/A
Completed	A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions NCT06282484	Xijing Hospital of Digestive Diseases	—
Unknown	A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure NCT05493644	Shandong University	—
Unknown	Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection NCT05364619	Peking University First Hospital	N/A
Recruiting	A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile NCT05926804	Miguel O'Ryan Gallardo	N/A
Completed	Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method) NCT05410652	Nanjing First Hospital, Nanjing Medical University	—
Unknown	Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection NCT05419674	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Completed	Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication NCT05469685	Nanjing First Hospital, Nanjing Medical University	Phase 4
Unknown	Effect of Hp Infection on the Quality of Gastric Mucosa Preparation NCT05527496	Second Affiliated Hospital of Xi'an Jiaotong University	—
Completed	Furazolidone Quadruple Regimen Eradicate H. Pylori Infection NCT06823791	Liaocheng People's Hospital	Phase 1 / Phase 2
Unknown	A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection NCT05483660	Nanfang Hospital, Southern Medical University	Phase 2
Completed	Human Mass Balance and Biotransformation Study of [14C]TNP-2198 NCT06137573	TenNor Therapeutics (Suzhou) Limited	Phase 1
Unknown	Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy NCT05455372	Second Affiliated Hospital of Xi'an Jiaotong University	N/A
Unknown	Epidemiology of Helicobacter Pylori Infection in Moscow NCT05775120	Moscow Clinical Scientific Center	—
Completed	Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Do NCT05431075	Shandong University	Phase 4
Completed	Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and A NCT06076694	TenNor Therapeutics (Suzhou) Limited	Phase 2
Unknown	Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequenci NCT05432115	Shandong University	Phase 4
Unknown	Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection NCT05320133	Peking University First Hospital	N/A
Completed	Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management NCT05614934	Alexandria University	Phase 4
Unknown	A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection NCT05590286	First People's Hospital of Hangzhou	Phase 4
Completed	Assessing the Histological Quality of Biopsy Samples Obtained With Multibite Forceps NCT05227079	Lawrence Charles Hookey	N/A
Completed	Helicobacter Pylori Eradication Therapy for Epileptic Children NCT05297695	Sohag University	Phase 2 / Phase 3
Recruiting	Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection NCT05332444	National Taiwan University Hospital	Phase 4
Unknown	The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylo NCT05189444	Huazhong University of Science and Technology	N/A
Unknown	Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment NCT05250050	Shanghai Zhongshan Hospital	Phase 4
Recruiting	Pathogen-microbiome Interaction During Helicobacter Pylori Infection NCT05121025	University Hospital Freiburg	—
Unknown	Bismuth Quadruple Therapy Versus Standard Triple Therapy NCT06143124	University Medical Centre Ljubljana	Phase 4
Completed	Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists NCT05065138	Shandong University	N/A
Unknown	Effect of Propolis on Patients Infected With H. Pylori NCT05259007	Fatma Zehra Arvas	Phase 4
Unknown	Influencing Factors of Helicobacter Pylori Infection and Eradication Failure NCT05226819	Second Affiliated Hospital of Xi'an Jiaotong University	N/A
Completed	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication NCT07167511	Yueyue Li	—
Completed	The Effects of Yogurt on Gut Microbiome and Metabolism in H. Pylori. NCT05374980	Taichung Veterans General Hospital	N/A
Completed	The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure NCT05173493	Shandong University	—
Recruiting	Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gast NCT05762991	National Taiwan University Hospital	—
Unknown	Arrangement of Collecting Venules for the Endoscopic Diagnosis of Helicobacter Pylori NCT05046990	Hospital Clinic of Barcelona	—
Completed	Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Erad NCT05014334	Xijing Hospital of Digestive Diseases	Phase 4
Completed	Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori NCT05191875	The Third Xiangya Hospital of Central South University	N/A
Unknown	Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin NCT05135182	Shandong University	Phase 4
Unknown	Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin NCT05129176	Shandong University	Phase 4
Unknown	Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection NCT05126121	Xiuli Zuo	N/A
Unknown	Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection NCT05133193	Shandong University	N/A
Active Not Recruiting	HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarctio NCT05024864	Karolinska Institutet	N/A
Recruiting	Helicobacter Pylori Eradication and Follow-up NCT05061732	Shanghai Zhongshan Hospital	Phase 4
Completed	A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Comb NCT06076681	TenNor Therapeutics (Suzhou) Limited	Phase 1 / Phase 2
Completed	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication NCT05049902	Shandong University	Phase 4
Unknown	Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients NCT05023577	Shanghai Zhongshan Hospital	Phase 4
Unknown	Tetracycline Versus Doxycycline for HP Rescue Therapy NCT05018923	Shanghai Zhongshan Hospital	Phase 4
Unknown	PPI-amoxicillin for H. Pylori Treatment NCT05014685	Shanghai Zhongshan Hospital	Phase 4
Unknown	Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection NCT04991584	Shandong University	N/A
Completed	Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection NCT05861687	Finni Kollins	Phase 2 / Phase 3
Unknown	Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologis NCT04984382	Shandong University	N/A
Completed	The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori NCT04850209	Shandong University	N/A
Recruiting	Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study) NCT04147065	Incheon St.Mary's Hospital	Phase 4
Completed	Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong P NCT04918134	Shandong University	—
Completed	Comparison of Different Helicobacter Pylori Detection Methods in Patients With Chronic Atrophic Gastritis NCT04923113	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	Vonoprazan in Helicobacter Pylori Treatment an RCT NCT04901663	Dow University of Health Sciences	Phase 4
Unknown	Differences in the Eradication of Helicobacter Pylori by Different Therapies NCT05097846	wang xiaoyan	N/A
Unknown	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 an NCT04901117	Shandong University	Phase 4
Unknown	Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication NCT04907747	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Completed	Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori NCT04879992	Shanghai Jiao Tong University School of Medicine	N/A
Unknown	Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicob NCT05100446	Unidade Local de Saúde do Alto Ave, EPE	EARLY_Phase 1
Completed	Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications NCT04403087	Chuncheon Sacred Heart Hospital	Phase 4
Completed	ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronid NCT04853875	Mackay Memorial Hospital	Phase 4
Unknown	Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection NCT05410223	The Third Xiangya Hospital of Central South University	N/A
Recruiting	Helicobacter Pylori Local Prevalence and Antibiotic Resistance NCT05561504	Technical University of Munich	—
Completed	High-dose Dual Therapy with Different Administration Frequencies NCT05901051	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era NCT05035186	Alexandria University	N/A
Unknown	Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection NCT04674774	Incheon St.Mary's Hospital	N/A
Completed	Gastric Swab for Helicobacter Pylori Detection NCT05349578	Seoul National University Hospital	N/A
Completed	Minocycline for Helicobacter Pylori Rescue Treatment NCT06332599	Shanghai Jiao Tong University School of Medicine	—
Recruiting	Tegoprazan-containing Sequential for H. Pylori NCT06382493	Seoul National University Bundang Hospital	N/A
Unknown	Epidemiology of Helicobacter Pylori Infection in Children From Slovenia NCT05846061	University Medical Centre Ljubljana	—
Completed	Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadr NCT04697186	Xijing Hospital of Digestive Diseases	Phase 4
Unknown	The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital NCT04212585	Assiut University	—
Completed	The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adu NCT05399862	Universiti Kebangsaan Malaysia Medical Centre	N/A
Unknown	Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment NCT04667299	Shanghai Zhongshan Hospital	Phase 4
Completed	Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing NCT04678492	Xijing Hospital of Digestive Diseases	Phase 4
Completed	A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication NCT04660123	Xijing Hospital of Digestive Diseases	Phase 4
Unknown	LOAD VS Levofloxacine Concomitant NCT04626193	Damascus Hospital	Phase 4
Completed	A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Par NCT06081712	TenNor Therapeutics (Suzhou) Limited	Phase 1
Completed	Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspeps NCT04473079	Lallemand Health Solutions	Phase 2 / Phase 3
Completed	Rescue Therapy for Helicobacter Pylori Eradication Treatment NCT04531059	Shanghai Jiao Tong University School of Medicine	Phase 4
Withdrawn	Optimal Tailored Treatment for H. Pylori Infection NCT04462133	Incheon St.Mary's Hospital	N/A
Recruiting	Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection NCT04332848	National Taiwan University Hospital	Phase 4
Unknown	Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused NCT04432233	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Eradication of H. Pylori Infection With Moxifloxacin NCT05863858	Iyad Naeem Muhammad, PhD	Phase 3
Recruiting	Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children NCT04415983	Tanta University	Phase 3
Completed	Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies NCT04209933	Xijing Hospital of Digestive Diseases	Phase 4
Unknown	Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Trea NCT04359966	Slovenian Society for Gastroenterology and Hepatology	N/A
Enrolling By Invitation	The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication NCT04527055	National Cheng-Kung University Hospital	Phase 4
Completed	Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity NCT05475431	National Cheng-Kung University Hospital	—
Completed	Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients NCT04296513	Instituto Ecuatoriano de Enfermedades Digestivas	—
Completed	The Prevalence of Helicobacter Pylori in Shanghai, 2013 to 2019 NCT04636866	Shanghai Jiao Tong University School of Medicine	—
Completed	Endoscopic Biopsy to Detect Helicobacter Pylori NCT04237220	Hospital Universitario Dr. Jose E. Gonzalez	—
Completed	Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT NCT04128917	HK inno.N Corporation	Phase 3
Unknown	Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. NCT04107194	University of Bari	Phase 3
Unknown	Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy. NCT04566211	Kaohsiung Veterans General Hospital.	N/A
Completed	Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection NCT04167670	Phathom Pharmaceuticals, Inc.	Phase 3
Completed	Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy NCT04445948	Alexandria University	Phase 4
Completed	IMPROVEMENT in ERADICATION of H-PYLORI INFECTION NCT05701683	Liaquat National Hospital & Medical College	Phase 4
Unknown	The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicoba NCT04319991	Fooyin University	N/A
Unknown	Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin NCT04264663	Shandong University	Phase 4
Unknown	Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin NCT04122287	Shandong University	Phase 4
Terminated	Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori NCT04025983	Institute of Gastroenterology and Hepatology, Vietnam	N/A
Completed	The Role of Probiotics in the Eradication of Helicobacter Pylori NCT04178187	Evangelismos Hospital	N/A
Completed	The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life Observatio NCT04708405	Alexandria University	—
Unknown	Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication. NCT04090021	Konstantopoulio-Patission General Hospital of Nea Ionia	Phase 4
Completed	Rapid Urease Test for Helicobacter Pylori in Population Who Stop Proton Pump Inhibitor Less Than 2 Weeks Compa NCT04233684	King Chulalongkorn Memorial Hospital	N/A
Completed	High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment NCT04024527	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Diagnosis of Helicobacter Pylori Based on Gastric Collecting Venules NCT04000243	Hospital Clinic of Barcelona	—
Completed	Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study. NCT03976739	Xijing Hospital of Digestive Diseases	—
Completed	Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder a NCT03832465	Mackay Memorial Hospital	Phase 4
Completed	High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Pop NCT05342532	Icahn School of Medicine at Mount Sinai	Phase 4
Unknown	Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii NCT03997279	Clinical Centre of Serbia	Phase 4
Completed	Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradicatio NCT03897244	National Taiwan University Hospital	Phase 4
Completed	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Sing NCT06081699	TenNor Therapeutics (Suzhou) Limited	Phase 1
Unknown	One Sequencing Find All for Helicobacter Pylori Infection NCT03837990	Seoul National University Hospital	—
Unknown	A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis NCT03908619	Changi General Hospital	Phase 4
Unknown	Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection NCT03616405	Shandong University	Phase 4
Unknown	Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection NCT03726099	Shandong University	Phase 4
Completed	Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizol NCT04348786	Damascus Hospital	Phase 4
Completed	Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection NCT04621487	University of Split, School of Medicine	N/A
Unknown	Empirical vs Tailored Therapy for H. Pylori Infection NCT04006340	Seoul National University Hospital	N/A
Unknown	Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication NCT03802318	Chang Gung Memorial Hospital	N/A
Unknown	Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helic NCT03565484	Shandong University	Phase 4
Completed	Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacte NCT03658746	Shandong University	Phase 4
Unknown	A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection NCT03658733	Shandong University	Phase 4
Completed	Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy NCT03708848	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter NCT03688828	Huazhong University of Science and Technology	N/A
Completed	Tailored Therapy for Clarithromycin-Resistant H. Pylori NCT03431688	Kangdong Sacred Heart Hospital	N/A
Completed	Assessment and Management of Chronic Dyspepsia in Eastern Uganda NCT04525664	Washington University School of Medicine	EARLY_Phase 1
Completed	THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE NCT03757650	Fatih Sultan Mehmet Training and Research Hospital	Phase 4
Recruiting	Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy NCT05329636	Tel-Aviv Sourasky Medical Center	Phase 1 / Phase 2
Completed	Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies NCT03779074	Kaohsiung Veterans General Hospital.	Phase 3
Completed	Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment NCT05152004	Chang Gung Memorial Hospital	N/A
Unknown	Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication NCT03722433	National Taiwan University Hospital	Phase 4
Unknown	Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults NCT03730766	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazol NCT03609892	Xijing Hospital of Digestive Diseases	Phase 4
Recruiting	The GAstric Precancerous Conditions Study NCT04191551	Stanford University	—
Completed	Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in NCT03665428	Chuncheon Sacred Heart Hospital	Phase 4
Completed	Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection NCT03779087	Ping-I (William) Hsu, M.D.	N/A
Unknown	Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter P NCT03571230	Shandong University	Phase 4
Completed	Triple Therapy With Tegoprazan in H. Pylori Positive Patients NCT03498456	HK inno.N Corporation	Phase 3
Completed	ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION NCT03968302	Ziauddin University	Phase 2
Completed	Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt NCT04039412	Ayman Magd Eldin Mohammad Sadek	Phase 4
Completed	Dysplasia Detection and Helicobacter Pylori Eradication NCT03917836	Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis	—
Completed	Rapid Urease Test for Diagnosis Helicobacter Pylori Infection NCT03547544	Indonesia University	—
Completed	High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment NCT03557437	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection NCT03521726	Mackay Memorial Hospital	Phase 4
Completed	Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection NCT03524833	Mackay Memorial Hospital	Phase 4
Completed	Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection NCT03516669	Mackay Memorial Hospital	Phase 4
Completed	Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid T NCT03572777	Antonio Mestrovic	N/A
Unknown	The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection. NCT03583476	National Taiwan University Hospital	—
Unknown	Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. NCT03556254	National Taiwan University Hospital	Phase 4
Unknown	Dual-focus Magnification With Narrow-band Imaging in Helicobacter Pylori Infection NCT03973242	Kyunghee University Medical Center	N/A
Unknown	French Pediatric Helicobacter Pylori Observatory NCT03541876	Lille Catholic University	—
Completed	High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment NCT03405584	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Tailored Therapy for Helicobacter Pylori Rescue Treatment NCT03413020	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar NCT04132479	Kirby Institute	Phase 4
Unknown	Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection NCT03361267	Inha University Hospital	N/A
Unknown	Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients NCT03297242	Changhai Hospital	—
Unknown	Bismuth Based Quadruple Therapy 10 Days in Children NCT03299725	Queen Fabiola Children's University Hospital	Phase 4
Unknown	Helicobacter Pylori Infection in Renal Transplant Patients NCT03310255	Assiut University	—
Completed	Telephone-Based Re-education for Hp Eradication NCT03193450	First Affiliated Hospital Xi'an Jiaotong University	N/A
Completed	A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Pati NCT03317223	HK inno.N Corporation	Phase 3
Completed	The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Ente NCT06337604	TenNor Therapeutics Inc.	Phase 1
Unknown	Sequential Versus Quadruple Therapy in the Second-line Treatment NCT03208426	National Taiwan University Hospital	Phase 4
Completed	Helicobacter Pylori Eradication in Functional Dyspepsia NCT04697641	Sir Ganga Ram Hospital	N/A
Terminated	Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication NCT03925818	Università degli Studi di Sassari	N/A
Completed	ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator NCT03198507	RedHill Biopharma Limited	Phase 3
Completed	Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics NCT02905825	Meridian Bioscience, Inc.	Phase 3
Unknown	Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadrupl NCT03397680	Thammasat University	Phase 1
Completed	Intraluminal Therapy for Helicobacter Pylori Infection NCT03124420	Mackay Memorial Hospital	Phase 4
Unknown	Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Tre NCT02988089	Shandong University	Phase 4
Unknown	Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of He NCT03150394	Dr. Luis Fernandez	Phase 4
Completed	Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris NCT03411733	Sohag University	—
Unknown	A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pyl NCT03099876	Il-Yang Pharm. Co., Ltd.	—
Completed	Dexlansoprazole MR-Based Concomitant Quadruple Therapy NCT03829150	Chang Gung Memorial Hospital	N/A
Completed	Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects NCT03060746	DiaSorin Inc.	—
Completed	Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects NCT03060733	DiaSorin Inc.	—
Completed	Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment NCT02935010	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infect NCT02959255	Elpen Pharmaceutical Co. Inc.	Phase 4
Unknown	Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy NCT03321773	Kaohsiung Veterans General Hospital.	N/A
Completed	Tailored H. Pylori Eradication Based on Clarithromycin Resistance NCT03884348	Kangdong Sacred Heart Hospital	—
Completed	Helicobacter Pylori Infection Occurrence in Russia NCT04892238	Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology	—
Completed	Helicobacter Pylori Eradication Study NCT03130452	Inje University	Phase 4
Unknown	Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging NCT03011437	Kashgar 1st People's Hospital	—
Completed	Intragastric pH and Bismuth Effect for H. Pylori Eradication NCT02894892	National Taiwan University Hospital	N/A
Completed	A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjec NCT06190340	TenNor Therapeutics (Suzhou) Limited	Phase 1
Unknown	10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication NCT03134378	Indonesia University	Phase 4
Unknown	Helicobacter Pylori Antibiotic Susceptibility Testing of Korea NCT02961296	Asan Medical Center	—
Completed	Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait NCT04617613	Al-Azhar University	Phase 4
Unknown	Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Child NCT02654197	Hillel Yaffe Medical Center	—
Completed	Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment NCT02732249	Shanghai Jiao Tong University School of Medicine	Phase 4
Unknown	Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer NCT04989153	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Unknown	Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility T NCT02759029	Gangnam Severance Hospital	N/A
Completed	Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy NCT03383003	Chang Gung Memorial Hospital	N/A
Completed	Tailored Juice-guided Eradication Therapy NCT04061447	Kaohsiung Medical University	N/A
Unknown	Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy NCT02894268	Sir Run Run Shaw Hospital	Phase 4
Completed	Eradication of Helicobacter Pylori With a Lactobacillus Reuteri Strain Plus Proton Pump Inhibitor NCT03404440	University of Bari	N/A
Completed	Optimal Site for Rapid Urease Test in the Stomach NCT02945137	Soonchunhyang University Hospital	—
Unknown	The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori NCT03220542	Kyunghee University Medical Center	Phase 4
Completed	Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp NCT03065868	Kyungpook National University Hospital	Phase 4
Completed	Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy NCT02646332	Kaohsiung Veterans General Hospital.	N/A
Completed	Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection NCT02528721	Meridian Bioscience, Inc.	Phase 3

Showing the 300 most recent trials. Use search for older records.